Ralph Schiess
Directeur Général chez ONCONETIX, INC.
Fortune : 32 370 $ au 30/04/2024
Profil
Ralph Schiess is the founder and Chief Executive Officer of Proteomedix AG, a company founded in 2010.
He is currently the Chief Executive & Science Officer at Onconetix, Inc., a position he started in 2023.
Dr. Schiess has a graduate degree from the University of Zurich and a doctorate degree from the Swiss Federal Institute of Technology.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ONCONETIX INC
1,21% | 05/04/2024 | 269 749 ( 1,21% ) | 32 370 $ | 30/04/2024 |
Postes actifs de Ralph Schiess
| Sociétés | Poste | Début |
|---|---|---|
| ONCONETIX, INC. | Directeur Général | 12/01/2024 |
ProteoMediX AG
 ProteoMediX AG BiotechnologyHealth Technology ProteoMediX AG operates in the identification of novel biomarkers for the early detection of cancer and the personalized treatment. The firm products include Prostate cancer detection, stratification and prognosis. The company was founded by Ralph Schiess, Christian Br?hlmann and Wilhelm Krek in 2010 and is headquartered in Schlieren, Switzerland. | Directeur Général | 01/01/2010 |
Formation de Ralph Schiess
| University of Zurich | Graduate Degree |
| Swiss Federal Institute of Technology | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ONCONETIX, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
ProteoMediX AG
ProteoMediX AG BiotechnologyHealth Technology ProteoMediX AG operates in the identification of novel biomarkers for the early detection of cancer and the personalized treatment. The firm products include Prostate cancer detection, stratification and prognosis. The company was founded by Ralph Schiess, Christian Br?hlmann and Wilhelm Krek in 2010 and is headquartered in Schlieren, Switzerland. | Health Technology |